BNET Industries

Market Cap:$60.5B
Last Fiscal Year Sales:$22.3B
  • Public
  • US
Dow Jones Description

Wyeth is one of the world?s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company?s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.

President and Chief Executive OfficerBernard Poussot
Number of Employees 100
Contact Information

5 Giralda Farms

Madison, New Jersey 07940-1027

www.wyeth.com

(973) 660-5000

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Wyeth extends collaboration deal with Trubion

    6/22/09 - Joint Venture / Alliance - View Story

  • Wyeth extends collaboration deal with Trubion

    6/22/09 - Joint Venture / Alliance - View Story

  • Mass. AG Martha Coakleys Office Files Complaint Against Drug Manufacturer Wyeth

    6/23/09 - Lawsuit Filed - View Story

  • Capital markets save dealmakers' fees as M&A wilts

    6/26/09 - Merger / Acquisition - View Story

  • Pfizer Registration Statement Relating To Pending Wyeth

    6/18/09 - Merger / Acquisition - View Story

  • REG-Pfizer Inc Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC

    6/18/09 - Merger / Acquisition - View Story

  • Two Possible Upcoming Approvals for Spectrum Pharmaceuticals

    6/12/09 - Merger / Acquisition - View Story

  • Wyeth WYE Approves $0.30 Per Share Dividend

    6/11/09 - Stock Split / Dividend - View Story

  • New Report Forecasts More Than Doubling of Vaccine Sales by 2013

    6/12/09 - Product Announcement - View Story

  • Drugmaker's ghostwriting is under fire

    6/15/09 - Lawsuit Filed - View Story

  • SEC declares S-4 of Pfizer effective for Wyeth acquisition

    6/18/09 - Merger / Acquisition - View Story

  • BUYINS.NET: Market Maker Surveillance Report. Top 6 Highest Net Buy Volume With Lowest Price Friction...

    6/03/09 - Joint Venture / Alliance - View Story

  • Bristol-Myers, Elan Talks Break Down: Report

    6/03/09 - Joint Venture / Alliance - View Story

  • Hedge funds face serious trimming

    5/31/09 - Merger / Acquisition - View Story

  • US and 16 States Sue Wyeth over Medicaid Discounts

    6/02/09 - Lawsuit Filed - View Story

  • Wyeth profit tops forecast but revenue disappoints

    5/23/09 - Financial Announcement - View Story

  • U.S., States Join Suits on Wyeth Sales

    5/21/09 - Legal Settlement - View Story

  • IDB approves tax breaks for Pfizer, Pacific Paper; 173 new jobs for Memphis

    5/20/09 - Merger / Acquisition - View Story

  • Today's World Recession Now Slowing Down Global Pharmaceutical Market

    6/02/09 - Merger / Acquisition - View Story

News & Analysis

wyeth - All News and Analysis

Decision Makers

Name (plus bio) Position
Bernard Poussot President and Chief Executive Officer
Richard Feldheim President
Gregory Norden Chief Financial Officer
Jeffrey E. Keisling Chief Information Officer
Andrew F. Davidson Principal Corporate Officer & Vice President, Internal Audit
Craig Conklin Vice President, Media Buying
David A. Manspeizer Vice President - Intellectual Property
Debby Lissaur Vice President & Manager, Advertising, DTC
Douglas A. Dworkin Vice President
Eileen M. Lach Vice President
Emma Salgado Vice President, Traffic Operations
Ingrid Loeuis Vice President & Treasurer
John C. Kelly Vice President
Justin R. Victoria Vice President - Investor Relations
Leo C Jardot Vice President - Government Relations
Lucille Callahan Vice President & Manager, Advertising, OTC
Marilyn Feoranzo Vice President, Media Buying
Patricia Johnson Vice President, Media Buying
Diane Betz Director, Info Services
Diane McGuire Director, Info Services
Marianne McArdle Executive Vice President & Media Buying Director
Steven Palmisano Senior Vice President & Advertising Director
Denise Peppard Senior Vice President - Human Resources
Joseph Mahady Senior Vice President
Lawrence V. Stein Senior Vice President
Mary Katherine Wold Senior Vice President - Finance
Mikael Dolsten Senior Vice President
Thomas Hofstaetter PhD Senior Vice President - Corporate Business Development
Timothy Cost Senior Vice President - Corporate Affairs
Robert E. Landry Jr. Treasurer

Board of Directors

Name (plus bio) Position
Ivan G. Seidenberg Board of Directors
Michael J Critelli Board of Directors
Raymond McGuire Board of Directors
Robert M. Amen Board of Directors
Victor F. Ganzi Board of Directors
Organization Position Status
Eisenhower Fellowships Chairman, President and CEO, Wyeth Current
Thiakis Limited Chairman, President and Chief Executive Officer Current
Facc Philadelphia Chairman, President and Chief Executive Officer, Wyeth Current
Wyeth President and Chief Executive Officer Current
Wyeth Chairman Current
Eisenhower Fellowships Board of Trustees Current
French-American Chamber of Commerce Board of Directors Current
Opera Company of Philadelphia Co Board of Directors Current
Opera Incorporated Board of Directors Current
Wyeth Chief Operating Officer Former
Wyeth Vice Chairman Former
University of Pennsylvania School of Dental Medicine Board of Directors Former
Organization Position Status
Wyeth President Current

Mr. Norden, previously Executive Vice President and Chief Financial Officer at Wyeth Pharmaceuticals, has been with Wyeth since 1989. He has held positions of increasing responsibility, including Senior Vice President, Finance and Chief Financial Officer, American Home Food Products; and Senior Vice President and Chief Financial Officer, Wyeth Laboratories -- North America. He served as Executive Vice President and Chief Financial Officer, Wyeth Pharmaceuticals since 2000. Prior to joining Wyeth, Mr. Norden was employed by Arthur Andersen & Company in New York. He has earned an undergraduate degree from the State University of New York at Plattsburgh and a Master of Science in Accounting from C. W. Post College. He is also licensed as a certified public accountant.

Organization Position Status
Wyeth Chief Financial Officer Current
Wyeth Senior Vice President Current

Mr. Keisling joined Wyeth in 2000 and was responsible for Information Services for Wyeth Pharmaceuticals. Prior to joining Wyeth, he was Senior Vice President and Chief Information Officer of Advanta Financial Services. In addition, he spent twelve years with Rhone-Poulenc Rorer Pharmaceuticals in a range of executive leadership positions including Chief Information Officer from 1995-1998. Mr. Keisling received his degree from Indiana University of PA. He is a Director of Answerthink Consulting Inc and is a Board member of Pharmaceutical Information Services Association (PISA).

Organization Position Status
Wyeth Chief Information Officer Current
Wyeth Vice President - Corporate Information Services Current
Organization Position Status
Wyeth Principal Corporate Officer & Vice President, Internal Audit Current
Organization Position Status
Wyeth Vice President, Media Buying Current

Mr. Manspeizer comes to Wyeth from Finnegan, Henderson, Farabow, Garrett & Dunner, LLP in Washington, D.C., where he served as a Partner since 2000 and an Associate since 1991. Mr. Manspeizer received a Bachelor of Arts degree from the University of Pennsylvania and a Juris Doctor degree from Rutgers University School of Law.

Organization Position Status
Wyeth Vice President - Intellectual Property Current
Wyeth Associate General Counsel Current
Organization Position Status
Wyeth Vice President & Manager, Advertising, DTC Current

Mr. Dworkin comes to Wyeth from Arnold & Porter in Washington, D.C. where he served as a Partner since 2001, and previously as Partner from 1985 to 1997. From 1997 to 2001, Mr. Dworkin served in the Department of Defense, first as Deputy General Counsel and then as General Counsel. Mr. Dworkin received a Bachelor of Arts degree from Oberlin College, a Master of Arts degree in International Relations at Yale University, and a Juris Doctor degree from Yale Law School.

Organization Position Status
Wyeth Vice President Current
Wyeth Deputy General Counsel Current

Ms. Lach joined the Corporation as Special Counsel - International in 1989 and was promoted to Assistant General Counsel in 1992. She became Corporate Secretary in 1997 and was promoted to Associate General Counsel - International in 2000. Prior to joining Wyeth, Ms. Lach had been a partner at Drinker, Biddle & Reath, where she had practiced international corporate and commercial law. Ms. Lach received her B.A., magna cum laude, from the University of Minnesota. She holds a J.D. from New York University School of Law and a master’s degree from Princeton University.

Organization Position Status
Wyeth Vice President Current
Wyeth Corporate Secretary Current
Wyeth Associate General Counsel Current
Organization Position Status
Wyeth Vice President, Traffic Operations Current
Organization Position Status
Wyeth Vice President & Treasurer Current

Since joining Wyeth in 2002, Mr. Kelly has handled a wide range of assignments in finance, most recently as Vice President, Finance Operations. Prior to joining Wyeth, he was at Arthur Andersen LLP for more than 35 years where he served as a Partner in the firm, the Partner in Charge of the Audit & Business Consulting Practice of Metro New York, and Managing Partner and Head of Accounting & Audit Practice for the firm’s New Jersey-based operations. He is a certified public accountant and was an elected member of the Council of the American Institute of Certified Public Accountants. He earned both his B.S. in business administration and M.B.A. in international finance from Seton Hall University.

Organization Position Status
Wyeth Vice President Current
Wyeth Controller Current
Organization Position Status
Wyeth Vice President - Investor Relations Current
Organization Position Status
Wyeth Vice President - Government Relations Current
Meridian International Center Board of Directors Current
Organization Position Status
Wyeth Vice President & Manager, Advertising, OTC Current
Organization Position Status
Wyeth Vice President, Media Buying Current
Organization Position Status
Wyeth Vice President, Media Buying Current
Organization Position Status
Wyeth Director, Info Services Current
Organization Position Status
Wyeth Director, Info Services Current
Organization Position Status
Wyeth Executive Vice President & Media Buying Director Current
Organization Position Status
Wyeth Senior Vice President & Advertising Director Current
Organization Position Status
Wyeth Pharmaceuticals, Inc. Head, Human Resources Current
Wyeth Senior Vice President - Human Resources Current
Wyeth Pharmaceuticals, Inc. Vice President, Human Resources Former
Organization Position Status
Wyeth Pharmaceuticals, Inc. President, Pharmaceuticals Division Current
Wyeth Senior Vice President Current
Wyeth Pharmaceuticals, Inc. President, Wyeth North America Former
Organization Position Status
Mynladatest Senior Vice President and General Counsel, Wyeth Current
Wyeth Senior Vice President Current
Wyeth General Counsel Current

Ms. Wold joined Wyeth as Vice President – Taxes in 2002 with responsibility for the Corporation’s worldwide tax matters. In 2005, she assumed the position of Senior Vice President – Tax and Treasury. Prior to joining Wyeth, Ms. Wold was a partner in the New York law firm of Shearman & Sterling beginning in 1988 and was the head of its worldwide tax practice group from 1995 through 2000. Ms. Wold earned an undergraduate degree from Hamline University in St. Paul, Minn., where she was elected a member of Phi Beta Kappa. She earned her J.D. from the University of Michigan Law School.

Organization Position Status
Wyeth Senior Vice President - Finance Current

Dr. Dolsten, previously was Executive Vice President within Pharmaceutical Research & Development/Medicine at Boehringer Ingelheim. He was responsible for leading the company’s worldwide pharmaceutical research in the U.S., Canada, Germany, Italy, Austria and Japan – with major programs in seven therapeutic areas including respiratory, inflammation/immunology, oncology, virology, cardiovascular, metabolism and CNS. In addition, he was a member of the corporate management team responsible for reviewing all worldwide development projects and licensing opportunities. Prior to joining Boehringer Ingelheim, Dr. Dolsten spent more than 15 years in various leadership roles in pharmaceutical research including positions with AstraZeneca and Pharmacia & Upjohn. Dr. Dolsten earned his Ph.D. in tumor immunology and M.D. from the University of Lund in Sweden. He also studied virology and cell biology at the Weizmann Institute in Israel and has been appointed as Adjunct Professor in Immunology at the Medical Faculty in Lund.

Organization Position Status
Wyeth Senior Vice President Current
Boehringer Ingelheim Corporation Head Current
Mdl Information Systems, Inc. Board of Directors Current
University of Lund M.D. Former

Dr. Hofstaetter comes to Wyeth from Aventis, where he served as Senior Vice President, Corporate Development. Prior to the merger that created Aventis, Dr. Hofstaetter was Senior Vice President, Business Development and Strategic Planning, for Hoechst Marion Roussel from 1995 through 1998 and was Executive Managing Director of Hoechst Japan Pharmaceuticals from 1991 to 1994. He previously worked for Behringwerke AG in Germany, where he started as a Research Scientist in 1978 and rose to Head of Research in 1988. Dr. Hofstaetter received his Ph.D. in Biochemistry/Molecular Biology, magna cum laude, from the University of Tuebingen in Germany.

Organization Position Status
Wyeth Senior Vice President - Corporate Business Development Current
Organization Position Status
ARAMARK Corporation Executive Vice President, Corp Affairs Current
Wyeth Senior Vice President - Corporate Affairs Current
Pharmacia Corporation Senior Vice President, Corporate Affairs Former
Centocor, Inc. Senior Vice President, Strategic Operations Former
Bristol-Myers Squibb Company Vice President, Investor Relations and Corporate Intelligence Former

Ivan Seidenberg is chairman of the board and chief executive officer of Verizon. Under Seidenberg's leadership, Verizon has become a premier network company, providing customers with the most advanced and innovative broadband experiences. Seidenberg was instrumental in forming Verizon through a number of mergers and acquisitions, including Bell Atlantic and NYNEX (1997), GTE (2000) and MCI (2006). He also helped create what is now Verizon Wireless in 1999 by bringing together the assets of Bell Atlantic Mobile, GTE Wireless and the U.S. properties of Vodafone AirTouch. Seidenberg has led Verizon since its inception, first as co-CEO in 2000, then as sole CEO since 2002 and chairman of the board since 2004. Verizon now operates an advanced global Internet backbone, a premier national wireless network and with the company's deployment of its high-speed, fiber-optic FiOS technology a next-generation broadband network. Verizon's leadership in network innovation has earned the company numerous citations and awards, including being named to the BusinessWeek 50, which represents the "best in class" from each sector of the S&P 500. Prior to the creation of Verizon, Seidenberg was chairman and CEO of Bell Atlantic and NYNEX. He began his communications career more than 40 years ago as a cable splicer's assistant and has held numerous operations and engineering assignments, including various leadership positions at NYNEX and Bell Atlantic. Seidenberg has a long-standing commitment to education and has made Verizon a leader in finding innovative ways to use communications technology to improve educational and literacy performance in the U.S. He also champions diversity both within and outside the company, and under his leadership Verizon's commitment to diversity has been widely recognized.

Organization Position Status
Verizon Communications Inc. Chairman & Chief Executive Officer Current
The Business Roundtable Chairman, Health and Retirement Task Force Current
Verizon Communications Inc. Board of Directors Current
Museum of Television & Radio Board of Directors Current
New York Hall of Science Board of Directors Current
Wyeth Board of Directors Current
NYNEX Chairman & Chief Executive Officer Former
Verizon Communications Inc. Co-CEO Former
Honeywell International Inc. Board of Directors Former
Pace University Master's Degree, Business Administration and Marketing Former
Lehman College Bachelor's Degree, Mathematics Former
Organization Position Status
Pitney Bowes Document Messaging Technologies Executive Chairman Current
Wyeth Board of Directors Current

Raymond McGuire is the Co-Head of Global Investment Banking, based in New York. He has responsibility for managing the coverage of global industries and clients and executing strategic transactions. Mr. McGuire is a member of the Institutional Clients Group Management Committee and the Institutional Clients Group Business Practices Committee. He is also a member of Citi's Senior Leadership Committee. Prior to joining Citi, Mr. McGuire was the Global Co-Head of Mergers & Acquisitions at Morgan Stanley; Managing Director in the Mergers and Acquisitions Group of Merrill Lynch & Co., Inc.; and one of the original members of Wasserstein Perella & Co., Inc. where he became a Partner/Managing Director in 1991. He started his career in 1984 in the Mergers and Acquisitions Group of The First Boston Corporation. Presently, Mr. McGuire serves on several boards including: De La Salle Academy (Chairman of the Board), the International Center of Photography (formerly President of the Board), Lincoln Center (Trustee), New York-Presbyterian Hospital (Trustee), The New York Public Library (Trustee), the Studio Museum in Harlem (Chairman of the Board), the Alex Hillman Family Foundation (Trustee), Whitney Museum of American Art (Vice President and Chairman of the Nominating Committee). He is also a Director of the Wyeth Corporation (Nominating & Governance Committee). In the past, he has served on the boards of the Joseph & Claire Flom Foundation, the Howard Gilman Foundation, the Hotchkiss School, and the San Remo Tenants' Corporation (formerly President of the Board). He has also served on various Visiting Committees at Harvard University, as well as a member of the Overseers/Directors Nominating Committee. In May 2008, he was bestowed the Frederick Douglas Award by the New York Urban League. In April 2008, he was inducted by Morehouse College as one of the inaugural members of the Martin Luther King, Jr. International Board of Renaissance Leaders. In October 2006, he was featured on the cover of Black Enterprise Magazine as one of the most powerful Blacks on Wall Street. He was recognized by Avenue Magazine as on of New York's "50 Smartest". Mr. McGuire has been honored by the Make-A-Wish Foundation and Art for Life Foundation. Pratt Institute honored him as its inaugural distinguished "Patron of the Arts". He has also been honored with Harvard Business School's African-American Student Union's Professional Achievement Award, has presented at Harvard Law School's Traphagen Distinguished Alumni Speaker Series and emceed the first Harvard College Black Alumni Weekend. He received his MBA and JD from Harvard Business School and Harvard Law School (1984), and an AB, cum laude, from Harvard College (1979). He also attended the University of Nice, France while on a Rotary Fellowship (1980). He has had legal experience at the law firms of Skadden, Arps, Slate, Meagher & Flom as well as Patterson, Belknap, Webb & Tyler.

Organization Position Status
Citigroup Inc. Co-Head, Global Investment Banking, Institutional Clients Group Current
Whitney Museum of American Art Vice Chairman and Investment Committee Chairman Current
Wyeth Board of Directors Current
Wasserstein Perella Managing Director Former
Merrill Lynch & Co., Inc. Managing Director Former
Wasserstein Perella Partner Former
Morgan Stanley Head of Mergers & Acquisitions Former
The First Boston Corporation Former

Mr. Landry began his career at Wyeth Pharmaceuticals in 1988. In 2004, he was appointed Chief Financial Officer of Wyeth Pharmaceuticals in Australia and New Zealand. In 2006, he was promoted to Director, Sales and Marketing, Wyeth Australia.

Organization Position Status
Wyeth Treasurer Current

Robert M. Amen was elected Chairman and Chief Executive Officer of IFF on July 1, 2006. Mr. Amen most recently served as President of International Paper Company, retiring from that post in March 2006. During his 26 years with International Paper, Mr. Amen played a major role in developing the company’s international strategy and, more recently, in transforming the company’s operations and business focus to accelerate performance. He was named president of International Paper in 2003, having previously served as executive vice president of the company from 2000-2003 and president of International Paper Europe from 1996-2000. He is currently a member of the Wyeth Board of Directors, and sits on the Advisory Board of the Deming Center at Columbia University. In addition, he is a member of the Board of the Inner City Scholarship Fund and the Personal Care Products Council. He also serves on the Leadership Committee of the Lincoln Center Corporate Fund. Mr. Amen is a Knight of Malta. Mr. Amen has a bachelor's degree in economics from Boston College and a master's degree in business administration from Columbia University.

Organization Position Status
International Flavors & Fragrances, Inc. Chairman and Chief Executive Officer Current
Inner-City Scholarship Fund Board of Directors Current
Wyeth Board of Directors Current
Columbia University Master's Degree In Business Administration Former
Boston College Bachelor's Degree In Economics Former
Organization Position Status
The Hearst Foundation, Inc. Board of Directors Current
Gentiva Health Services, Inc. Board of Directors Current
Thiakis Limited Board of Directors Current
PGA Tour, Inc. Board of Directors Current
Wyeth Board of Directors Current
The Hearst Corporation President & Chief Executive Officer Former
Hearst-Argyle Television, Inc. Chairman Former
Olsten Corporation Director Former
Harvard Law School J.D. degree Former
New York University L.L.M. in Taxation Former
Fordham University Former

Executive News

  • Verizon to Carry HTC Ozone

    Wireless Week - 6/25/09 - View Story

  • Vaccine Pioneer Joins Inovio Biomedical's Scientific Advisory Board

    Pharma Live - 6/24/09 - View Story

  • Vaccine Pioneer Joins Inovio Biomedical’s Scientific Advisory Board

    Freshnews.com - 6/24/09 - View Story

  • Vaccine Pioneer Joins Inovio Biomedical's Scientific Advisory Board

    Street Insider - 6/24/09 - View Story

  • Vaccine Pioneer Joins Inovio Biomedicals Scientific Advisory

    Business Wire via MSN Money - 6/24/09 - View Story

  • Vaccine Pioneer Joins Inovio Biomedical's Scientific Advisory Board

    RBC Dain Raushcer - 6/24/09 - View Story

  • Vaccine Pioneer Joins Inovio Biomedicals Scientific Advisory Board

    Business Wire - 6/24/09 - View Story

  • Fed mulls tweaks to economic revival programs

    Seattle Times - 6/24/09 - View Story

  • Fed mulls tweaks to economic revival programs

    Washington Post - 6/24/09 - View Story

  • TOPWRAP 7-Obama, world data suggest slow, or no, recovery

    Forbes.com - 6/23/09 - View Story

  • STOCKS NEWS US-Lab Corp to buy Monogram for $106.7 mln

    Forbes.com - 6/23/09 - View Story

  • STOCKS NEWS US-Justice Department not planning to drop UBS case

    Forbes.com - 6/23/09 - View Story

  • Sarah Palin's CIO on Hunting for Bear and IT Staff

    Computerworld - 6/22/09 - View Story

  • Momenta Pharmaceuticals names new board member

    TradingMarkets - 6/15/09 - View Story

  • Momenta Pharmaceuticals, Inc. (MNTA) Announces Appointment of Bruce L. Downey to Board of Directors

    BioSpace - 6/12/09 - View Story

  • Momenta Pharmaceuticals Announces Appointment of Bruce L. Downey to Board of Directors

    Interest!ALERT - 6/12/09 - View Story

  • Momenta Pharmaceuticals Announces Appointment of Bruce L. Downey to Board of Directors

    Therapeutics Daily - 6/12/09 - View Story

  • Momenta Pharma names Bruce Downey to board, effective June 11 -Quick Facts

    RTTNews.com - 6/12/09 - View Story

  • Momenta Pharmaceuticals Announces Appointment of Bruce L. Downey to Board of Directors

    Yahoo! Canada - 6/12/09 - View Story

  • PHARMA MARKET: Wyeth Stands By Pristiq After Slow Start

    CNN Money - 6/10/09 - View Story

advertisement
     WYE $29.81 -15.56 (-34.30% )
Average Volume 11,307,500
Shares Outstanding 1.33B
Market Cap 39.8B
Year High 49.8
Year Low 25
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement